Clinical TrialsSearch results
Number of results: 596
Other
- A multicenter study on warfarin use and optimal anticoagulation levels for prevention of cardiogenic embolism in Japanese patients with atrial fibrillation: J-RHYTHM Registry
- atrial fibrillation
- The Japanese Society of Electrocardiology
- 2009-01-05
Other
- A multicenter, observational study for reactivation of hepatitis B virus by means of serial HBV-DNA monitoring during and just after systemic chemotherapy containing rituximab plus steroid for malignant lymphoma (C-SHOT 0802)
- Untreated CD20-positive, B-cell non-Hodgkin's lymphoma in the patients with seronegativity for HBsAg and seropositivity for HBc-Ab and/or HBs-Ab, which is planned to be treated with 6-8 courses of systemic chemotherapy containing rituximab plus steroid such as R-CHOP, R-CVP, R-THP-COP and R-C-MOPP
- Nagoya City University Hospital
- 2008-08-11
Other
- A multicentre study on clinical usefulness of urinary trypsinogen-2 for early diagnosis of acute pancreatitis.
- Definite or possible acute pancreatitis.
- Division of Gastroenterology, Tohoku University Graduate School of Medicine
- 2009-01-07
Other
- A non-randomized confirmatory study of Limited Surgical Resection for Peripheral Early Lung Cancer Defined with Thoracic Thin-section Computed Tomography (JCOG0804/WJOG4507L)
- small (2 cm or less) peripheral radiological non-invasive lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2009-05-26
Other
- A Phase 1/2 Trial of CLN-081 in Patients With Locally-Advanced or Metastatic Non-Small Cell Lung Cancer
- Non-small cell lung cancer harboring EGFR exon 20 insertion mutations
- Nasermoaddeli Ali
- 2023-04-30
Other
- A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervix
- stage 1b2/2 cervical cancer
- Japanese Gynecologic Oncology Group
- 2006-12-21
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Metformin
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Thiazolidine
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to an Alpha-Glucosidase Inhibitor
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01